Evidence map›Paper›PMID 37670329›Full record

ArticleCritical care (London, England)2023

Impact of Covid-19 on risk of severe maternal morbidity.

Nathalie Auger, U Vivian Ukah, Shu Qin Wei, Jessica Healy-Profitós, Ernest Lo, Natalie Dayan

Open access · goldAbstract read
In one paragraph

Article in Critical care (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Nathalie AugerUniversity of Montreal Hospital Research Centre, Montreal, QC, Canada. nathalie.auger@inspq.qc.ca.
U Vivian UkahInstitut national de santé publique du Québec, Montreal, QC, Canada.
Shu Qin WeiInstitut national de santé publique du Québec, Montreal, QC, Canada.
Jessica Healy-ProfitósUniversity of Montreal Hospital Research Centre, Montreal, QC, Canada.
Ernest LoInstitut national de santé publique du Québec, Montreal, QC, Canada.
Natalie DayanDepartment of Medicine, McGill University, Montreal, QC, Canada.
Institut National de Santé Publique du Québec · CAUniversité de Montréal · CAMcGill University · CA

Funding

CIHR PUU-177957
6 · The paper itself

Abstract

backgroundWe examined the risk of severe life-threatening morbidity in pregnant patients with Covid-19 infection.

methodsWe conducted a population-based study of 162,576 pregnancies between March 2020 and March 2022 in Quebec, Canada. The main exposure was Covid-19 infection, including the severity, period of infection (antepartum, peripartum), and circulating variant (wildtype, alpha, delta, omicron). The outcome was severe maternal morbidity during pregnancy up to 42 days postpartum. We estimated risk ratios (RR) and 95% confidence intervals (CI) for the association between Covid-19 infection and severe maternal morbidity using adjusted log-binomial regression models.

resultsCovid-19 infection was associated with twice the risk of severe maternal morbidity compared with no infection (RR 2.02, 95% CI 1.76-2.31). Risks were elevated for acute renal failure (RR 3.01, 95% CI 1.79-5.06), embolism, shock, sepsis, and disseminated intravascular coagulation (RR 1.35, 95% CI 0.95-1.93), and severe hemorrhage (RR 1.49, 95% CI 1.09-2.04). Severe antepartum (RR 13.60, 95% CI 10.72-17.26) and peripartum infections (RR 20.93, 95% CI 17.11-25.60) were strongly associated with severe maternal morbidity. Mild antepartum infections also increased the risk, but to a lesser magnitude (RR 3.43, 95% CI 2.42-4.86). Risk of severe maternal morbidity was around 3 times greater during circulation of wildtype and the alpha and delta variants, but only 1.2 times greater during omicron.

conclusionsCovid-19 infection during pregnancy increases risk of life-threatening maternal morbidity, including renal, embolic, and hemorrhagic complications. Severe Covid-19 infection with any variant in the antepartum or peripartum periods all increase the risk of severe maternal morbidity.

Indexed as

COVID-19Disseminated Intravascular CoagulationPregnancy Complications, InfectiousCanadaFemaleHumansPregnancySARS-CoV-2Covid-19HemorrhagePregnancyRenal failureSARS-CoV-2Severe maternal morbidity

Identifiers

PMID37670329
PMCPMC10481463
OpenAlexW4386457403

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.